GlassScriptPhysician profile
Misty L Lawrence
NPI 1134633183
$2,148.60
in general payments reported to CMS, 2019-2025
26 companies · $416 in 2025
The $416 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $31.19 · 2022: $186 · 2023: $829 · 2024: $687 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,932.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,931.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $556.34 | 2021-2025 | Lifevest |
| Amgen INC. | $228.83 | 2023-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $157.46 | 2023-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $138.63 | 2024-2025 | |
| Abbott Laboratories | $136.74 | 2023 | Ensite |
| Edwards Lifesciences Corporation | $131.16 | 2024 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $115.14 | 2024 | Watchman Flx |
| Kiniksa Pharmaceuticals International, Plc | $77.55 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $73.99 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.78 | 2024 | Jardiance |
| Cvrx, INC. | $50.74 | 2024-2025 | Barostim Neo System |
| Novo Nordisk INC | $48.91 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Stryker Corporation | $45.30 | 2025 | Flowtriever |
| Heartflow, INC. | $45.11 | 2023-2024 | Ffrct |
| Astrazeneca Pharmaceuticals LP | $36.62 | 2023 | Farxiga, Andexxa |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $29.67 | 2023 | Xarelto |
| Alnylam Pharmaceuticals INC. | $29.09 | 2025 | Amvuttra |
| Irhythm Technologies, INC. | $27.03 | 2023 | Zio Xt Patch |
| Pfizer INC. | $23.71 | 2023 | |
| Medtronic, INC. | $23.30 | 2023 | Micra |
| Inogen, INC. | $22.01 | 2025 | |
| Vivaquant INC, Dba Rhythm Express | $20.48 | 2025 | Rhythm Express |
| Chiesi USA, INC. | $20.45 | 2023 | Kengreal, Cleviprex |
| Baxter Healthcare | $20.34 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Inspire Medical Systems, INC. | $19.14 | 2025 | Inspire |
| Sanofi-Aventis U.S. LLC | $18.08 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Misty Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.